Institutional shares held 41.1 Million
139K calls
20.6K puts
Total value of holdings $84.2M
$285K calls
$42K puts
Market Cap $153M
74,790,096 Shares Out.
Institutional ownership 54.91%
# of Institutions 89


Latest Institutional Activity in STXS

Top Purchases

Q3 2024
Northern Trust Corp Shares Held: 464K ($951K)
Q3 2024
Cerity Partners LLC Shares Held: 124K ($254K)
Q3 2024
Geode Capital Management, LLC Shares Held: 1.39M ($2.85M)
Q3 2024
Morgan Stanley Shares Held: 161K ($330K)
Q3 2024
Barclays PLC Shares Held: 102K ($209K)

Top Sells

Q3 2024
Archon Capital Management LLC Shares Held: 1.28M ($2.63M)
Q3 2024
Warberg Asset Management LLC Shares Held: 203K ($416K)
Q3 2024
Renaissance Technologies LLC Shares Held: 362K ($743K)
Q3 2024
Lagoda Investment Management, L.P. Shares Held: 3.83M ($7.85M)
Q3 2024
Kovack Advisors, Inc. Shares Held: 124K ($254K)

About STXS

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.


Insider Transactions at STXS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
760K Shares
From 7 Insiders
Grant, award, or other acquisition 657K shares
Open market or private purchase 103K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on STXS

Follow Stereotaxis, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STXS shares.

Notify only if

Insider Trading

Get notified when an Stereotaxis, Inc. insider buys or sells STXS shares.

Notify only if

News

Receive news related to Stereotaxis, Inc.

Track Activities on STXS